singapore customs, is a personal quantity fine
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time
#asia 2026-04-26
- willow_waits — as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described 21:14
- bengaluru_bac — japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap 22:04
- willow_waits — the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you… 22:11
- willow_waits — closer supplier, fewer flight hours, same number of customs steps. the steps are the slow part 22:12
update on the earlier thing japan approved it a while back didnt it, what does it cost there
genuine question anyone shipped from inside the region and had it take longer than from further away
member reported range
[edited]update from 20 months ago: availability in the region is broadly the same and the prices i track are slightly higher, still working it out
On this day 8 years ago this channel logged 75 messages.
summer shipping matters here too. i avoid july and august the way australian members avoid january
a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic
the honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way
as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described
i treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested
japan approved it
coming back to this customs inside asia caught my parcel once in four years. that is my rate, not a regional statistic
[edited]customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border
closer isnt simpler
forty percent apart
japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap
slightly off topic but does anyone in hong kong want to compare prices
insurance in the region tracked the diabetes indication in every country a member reported on
the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received
closer supplier, fewer flight hours, same number of customs steps. the steps are the slow part
diabetes indication only